Test for determining the dose response of a conjugated vaccine
US5604108A · kind A · utility
1Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 1994 |
| Grant date | Feb 18, 1997 |
| Priority date | — |
| Expiry date | Jun 2, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The dosage response of humans to conjugate vaccines comprising a bacterial polysaccharide and a strongly-immunogenic carrier protein is determined in animals by coadministering to the animal unconjugated strongly-immunogenic carrier protein in an amount corresponding, on a weight-related basis, to that administered to the human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.